Several diagnostic and pathology vendors unveiled new products and services this week. Tempus launched Paige Predict, an AI pathology suite that estimates biomarker presence across cancer types; Navinci Diagnostics introduced the Naveni Plex Omni Service for spatial protein interaction mapping; Parse Biosciences added an integrated immune‑repertoire/whole transcriptome workflow to Trailmaker; and Zepto Life debuted a plasma‑based FungiFlex mold panel available through its CLIA lab. Separately, ACON Laboratories received FDA clearance for Flowflex, the first FDA‑cleared 4‑in‑1 home test for RSV, influenza A/B and COVID‑19 for ages six months and up, enabling rapid at‑home respiratory diagnostics. The product wave highlights continued demand for rapid, spatial and AI‑enabled diagnostics across oncology and infectious disease.